| 000 | 05237nam a22004695i 4500 | ||
|---|---|---|---|
| 001 | 978-981-97-1821-4 | ||
| 003 | DE-He213 | ||
| 005 | 20251030112004.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240422s2024 si | s |||| 0|eng d | ||
| 020 |
_a9789819718214 _9978-981-97-1821-4 |
||
| 024 | 7 |
_a10.1007/978-981-97-1821-4 _2doi |
|
| 050 | 4 | _aRC346-429.2 | |
| 072 | 7 |
_aMJN _2bicssc |
|
| 072 | 7 |
_aMED056000 _2bisacsh |
|
| 072 | 7 |
_aMKJ _2thema |
|
| 245 | 1 | 0 |
_aNeuropsychiatric Manifestations in Neurological Diseases _h[electronic resource] / _cedited by Jong S. Kim. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2024. |
|
| 300 |
_aVIII, 198 p. 2 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aPart 1 Stroke -- 1 Depression and anxiety in stroke -- 2 Emotional incontinence in stroke -- 3 Anger or aggression in stroke -- 4 Fatigue in stroke -- 5 Other neuropsychiatric symptoms including psychosis in stroke -- Part 2 Alzheimer disease and other dementia -- 6 Depression in dementia -- 7 Anxiety in dementia -- 8 Agitation in dementia -- 9 Apathy in dementia -- 10 Psychosis in dementia -- Part 3 Seizures and epilepsy -- 11 Psychosis in epilepsy -- 12 Depression in epilepsy -- 13 Anger or aggression in epilepsy -- 14 Anxiety in epilepsy -- 15 Apathy in epilepsy -- Part 4 Other neurological disorders -- 16 Neuropsychiatric manifestations in Parkinson's disease and other movement disorders -- 17 Neuropsychiatric Manifestations of Amyotrophic Lateral Sclerosis -- 18 Neuropsychiatric manifestations in multiple sclerosis and other demyelinating diseases -- 19 Neuropsychiatric manifestations in traumatic brain injury -- 20 Neuropsychiatric manifestations in brain tumor. | |
| 520 | _aPsychiatric symptoms (or mood/emotional disturbances) are diverse in patients with neurological diseases, that include depression, anxiety, emotional incontinence, anger, fatigue, and apathy. These symptoms are common; more than 1/3 of the patients suffer from these symptoms. Unfortunately, they have been neglected because 1) unlike other neurological symptoms such as motor dysfunction, speech disturbances or visual field defect, these symptoms are not visible and difficult to be noticed unless they are specifically examined by a physician who is properly educated on this problem 2) they are often not regarded as neurological symptoms either by the patients or their caregivers 3) they are relatively poorly studied by both neurologists and psychiatrists, and accordingly, are unfamiliar to the physicians. Especially, although `depression’ is well known to physicians, other symptoms such as emotional incontinence, anger, fatigue or apathy are not appropriately assessed by physicians, and frequently misdiagnosed as depression. Moreover, there are difficulties in diagnosing depression in patients neurological diseases. For example, the individual items included in depression diagnosis such as sleep disturbances, appetite loss, or fatigue can result from neurological diseases or comorbid physical conditions in patients with neurological diseases. Therefore, a diagnosis of `depression’ should be made cautiously. Finally, it should be understood that the importance of different mood/ emotional syndromes differ among various neurological diseases; for instance, although emotional incontinence and anger occur in as many as 20-30 % of stroke patients, apathy and fatigue are more important symptoms than these for patients with neuro-degenerative disease. In clinical practice, recognizing these symptoms is important because they negatively affect the patients’ quality of life, impair the functional recovery, increase the mortality, and increase the caregiver burden. Nevertheless, unlike other neurological symptoms such as motor/sensory dysfunction, and speech disturbances, they are relatively well managed mostly by pharmacological therapy such as selective serotonin re-uptake inhibitors (SSRI). The phenomenology of these neuropsychiatric symptoms and related factors, pathophysiological mechanism, and treatment strategies should be properly educated for neurologists, psychiatrists and other physicians. The book is written by experts in this field to disseminate important knowledges to neurologists, psychiatrists, psychologists and other physicians and will eventually benefit patients with neurological diseases. | ||
| 650 | 0 |
_aNeurology . _966816 |
|
| 650 | 1 | 4 |
_aNeurology. _966816 |
| 700 | 1 |
_aKim, Jong S. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _975539 |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819718207 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819718221 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819718238 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-981-97-1821-4 |
| 912 | _aZDB-2-SME | ||
| 912 | _aZDB-2-SXM | ||
| 999 |
_c59290 _d59290 |
||